Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation

Mesenchymal stem cells (MSCs) have been shown to improve the outcome of acute renal injury models; but whether MSCs can delay renal failure in chronic kidney disease (CKD) remains unclear. In the present study, the were cultured in media containing various concentrations of basic fibroblast growth f...

Full description

Bibliographic Details
Main Authors: Chang, Jei-Wen, Tsai, Hsin-Lin, Chen, Chang-Wei, Yang, Hui-Wen, Yang, An-Hang, Yang, Ling-Yu, Wang, Paulus S, Ng, Yee-Yung, Lin, Teng-Lung, Lee, Oscar K
Format: Online
Language:English
Published: BlackWell Publishing Ltd 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393722/